NCT01587040 2022-04-19Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination RegimenSanofiPhase 1/2 Completed61 enrolled 13 charts
NCT01943838 2016-04-22A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or LymphomaSanofiPhase 1 Completed18 enrolled
NCT01392924 2014-12-03Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid TumorsSanofiPhase 1 Completed10 enrolled